ID

25854

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Montral Cognitive Assessment (MoCA)

Mots-clés

Versions (1)
  1. 21/09/2017 21/09/2017 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

21 septembre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

Anglais

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulaires  
MoCA General information
Description

MoCA General information

1. Date of visit/assessment
Description

Date of visit/assessment

Type de données

date

Informed consent
Description

Informed consent

Type de données

text

MoCA Eligibility Question
Description

MoCA Eligibility Question

1. Did subject meet all MoCA eligibility criteria?
Description

MoCA eligibility criteria met

Type de données

text

[I51] 1. Availability of an approved translation
Description

Inclusion criterion

Type de données

boolean

[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
Description

Inclusion criterion

Type de données

boolean

[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
Description

Exclusion criterion

Type de données

boolean

Montreal Cognitive Assessment
Description

Montreal Cognitive Assessment

MoCA Status
Description

MoCA Status

Type de données

text

Montreal Cognitive Assessment (MoCA)
Description

Montreal Cognitive Assessment (MoCA)

Type de données

text

Retour au début de la page

Similar models

MoCA GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
MoCA General information
Date of visit/assessment
Item
1. Date of visit/assessment
date
Informed consent
Item
Informed consent
text
Item Group
MoCA Eligibility Question
Item
1. Did subject meet all MoCA eligibility criteria?
text
MoCA eligibility criteria met
Code List
1. Did subject meet all MoCA eligibility criteria?
CL Item
Yes (Y)
CL Item
No, please select all boxes corresponding to the criteria that were not met (N)
Availability of an approved translation
Item
[I51] 1. Availability of an approved translation
boolean
informed consent
Item
[I52] 2. Signed written informed consent prior to assessing the MoCA. Note: Consent to participate in the MoCA assessment is seperate from consent to participate in the parent study.
boolean
physical limitation
Item
[E51] 1. Inability to complete all items on the MoCA due to physical limitation(s)
boolean
Item Group
Montreal Cognitive Assessment
MoCA Status
Item
MoCA Status
text
Montreal Cognitive Assessment (MoCA)
Item
Montreal Cognitive Assessment (MoCA)
text
Retour au début de la page 

Contact

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial